I think we are seeing that in part from the FHFA Director Thompson, who is departing from risk-based pricing on individual loans purchased by the GSEs.
Editor's note · Context
Senator Scott critiques changes in risk-based pricing affecting credit access.
Share & report
More from Tim Scott
The Laffer Curve is right. ... It has always worked; I think it always will work.
Thank you, Coach. I will just simply say that although there are many, many people living in Alabama coming to the conclusion--it makes total sense to me. Alabama is a fine State. You guys produce national championships, and you know…
Clinical trials are critical to medical innovation, but too many Americans, especially those in rural and underserved communities, are left out.
For patients and families facing life-threatening diseases like sickle cell anemia, bone marrow and cord blood transplants can offer a cure and a second chance at life. The Stem Cell Therapeutic and Research Reauthorization Act of 2026…





